Elevation of plasma tRNA fragments as a promising biomarker for liver fibrosis in nonalcoholic fatty liver disease
Abstract Fibrotic tissue remodelling in nonalcoholic fatty liver disease (NAFLD) will probably emerge as the leading cause of end-stage liver disease in the coming decades, but the ability to diagnose liver fibrosis in NAFLD patients noninvasively is limited. The abnormal expression of tRNA-derived...
Guardado en:
Autores principales: | Peng Huang, Biao Tu, Hui-jun Liao, Fei-zhou Huang, Zhen-zhou Li, Kuang-ye Zhu, Feng Dai, Huai-zheng Liu, Tian-yi Zhang, Chuan-zheng Sun |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6f7b729e989f40e4bfaca615c3cff45c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
por: Gwyneth Shook Ting Soon, et al.
Publicado: (2021) -
Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease
por: Taeang Arai, et al.
Publicado: (2021) -
Association between liver fibrosis progression and endothelin-1/nitric oxide in patients with nonalcoholic fatty liver disease
por: LI Pinhua
Publicado: (2021) -
Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
por: Rui Xue, et al.
Publicado: (2021) -
Dietary patterns in relation to hepatic fibrosis among patients with nonalcoholic fatty liver disease
por: Soleimani D, et al.
Publicado: (2019)